Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Consolidated Net Income: 2015-2024

Historic Consolidated Net Income for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to -$145.2 million.

  • Anaptysbio's Consolidated Net Income rose 146.00% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year increase of 48.91%. This contributed to the annual value of -$145.2 million for FY2024, which is 11.24% up from last year.
  • According to the latest figures from FY2024, Anaptysbio's Consolidated Net Income is -$145.2 million, which was up 11.24% from -$163.6 million recorded in FY2023.
  • Anaptysbio's 5-year Consolidated Net Income high stood at -$19.9 million for FY2020, and its period low was -$163.6 million during FY2023.
  • Its 3-year average for Consolidated Net Income is -$145.9 million, with a median of -$145.2 million in 2024.
  • As far as peak fluctuations go, Anaptysbio's Consolidated Net Income spiked by 79.52% in 2020, and later tumbled by 189.98% in 2021.
  • Yearly analysis of 5 years shows Anaptysbio's Consolidated Net Income stood at -$19.9 million in 2020, then plummeted by 189.98% to -$57.8 million in 2021, then plummeted by 122.72% to -$128.7 million in 2022, then dropped by 27.11% to -$163.6 million in 2023, then climbed by 11.24% to -$145.2 million in 2024.